Montecito Bank & Trust Has Decreased Its Johnson & Johnson (JNJ) Holding by $370,630; As Proofpoint (PFPT) Share Price Rose, Stifel Financial Has Boosted by $746,982 Its Stake

January 21, 2018 - By Adrian Erickson

Montecito Bank & Trust decreased its stake in Johnson & Johnson (JNJ) by 8.56% based on its latest 2017Q3 regulatory filing with the SEC. Montecito Bank & Trust sold 2,851 shares as the company’s stock rose 6.85% with the market. The institutional investor held 30,442 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $3.96M, down from 33,293 at the end of the previous reported quarter. Montecito Bank & Trust who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $395.89B market cap company. The stock increased 0.30% or $0.44 during the last trading session, reaching $147.36. About 8.74M shares traded or 58.03% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 21, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Stifel Financial Corp increased its stake in Proofpoint Inc (PFPT) by 4.8% based on its latest 2017Q3 regulatory filing with the SEC. Stifel Financial Corp bought 8,586 shares as the company’s stock rose 0.42% with the market. The institutional investor held 187,430 shares of the technology company at the end of 2017Q3, valued at $16.34M, up from 178,844 at the end of the previous reported quarter. Stifel Financial Corp who had been investing in Proofpoint Inc for a number of months, seems to be bullish on the $4.46B market cap company. The stock increased 1.55% or $1.52 during the last trading session, reaching $99.57. About 391,605 shares traded. Proofpoint, Inc. (NASDAQ:PFPT) has risen 52.24% since January 21, 2017 and is uptrending. It has outperformed by 35.54% the S&P500.

Stifel Financial Corp, which manages about $28.81 billion US Long portfolio, decreased its stake in Powershares Act Mang Comm Fd by 33,529 shares to 76,067 shares, valued at $1.28M in 2017Q3, according to the filing. It also reduced its holding in Helmerich & Payne Inc (NYSE:HP) by 20,962 shares in the quarter, leaving it with 281,390 shares, and cut its stake in Marriott Intl Inc New (NASDAQ:MAR).

Since August 16, 2017, it had 0 insider purchases, and 16 sales for $20.38 million activity. Steele Gary also sold $3.54 million worth of Proofpoint, Inc. (NASDAQ:PFPT) shares. 3,000 Proofpoint, Inc. (NASDAQ:PFPT) shares with value of $266,965 were sold by Knight David. Hahn Eric sold 5,000 shares worth $452,667.

Investors sentiment decreased to 1.16 in 2017 Q3. Its down 0.16, from 1.32 in 2017Q2. It turned negative, as 26 investors sold PFPT shares while 77 reduced holdings. 34 funds opened positions while 85 raised stakes. 49.44 million shares or 0.58% less from 49.73 million shares in 2017Q2 were reported. Moreover, Rmb Capital Ltd has 0.17% invested in Proofpoint, Inc. (NASDAQ:PFPT) for 77,287 shares. Nationwide Fund Advisors holds 184,197 shares or 0.06% of its portfolio. Hhr Asset Management Ltd Liability Com stated it has 1.46% in Proofpoint, Inc. (NASDAQ:PFPT). Croft holds 0.16% in Proofpoint, Inc. (NASDAQ:PFPT) or 8,000 shares. Assetmark Incorporated accumulated 355 shares. Moreover, Susquehanna Int Group Inc Llp has 0% invested in Proofpoint, Inc. (NASDAQ:PFPT) for 27,658 shares. Peak6 Ltd Partnership has invested 0% in Proofpoint, Inc. (NASDAQ:PFPT). 209,196 were reported by Bnp Paribas Asset Hldgs. The New York-based Fred Alger Management has invested 0.22% in Proofpoint, Inc. (NASDAQ:PFPT). 123,671 are held by Elk Creek Prtnrs Ltd Liability. Alliancebernstein Limited Partnership holds 592,561 shares or 0.04% of its portfolio. Stanley owns 0.19% invested in Proofpoint, Inc. (NASDAQ:PFPT) for 8,220 shares. Walleye Trading Ltd Liability accumulated 17,550 shares or 0.01% of the stock. Eulav Asset Management stated it has 0.2% in Proofpoint, Inc. (NASDAQ:PFPT). Great West Life Assurance Communication Can holds 0% of its portfolio in Proofpoint, Inc. (NASDAQ:PFPT) for 5,247 shares.

Among 29 analysts covering Proofpoint Inc (NASDAQ:PFPT), 23 have Buy rating, 2 Sell and 4 Hold. Therefore 79% are positive. Proofpoint Inc had 77 analyst reports since July 24, 2015 according to SRatingsIntel. The company was initiated on Thursday, September 10 by Morgan Stanley. Goldman Sachs initiated the stock with “Neutral” rating in Monday, March 21 report. The rating was upgraded by Zacks on Tuesday, August 25 to “Sell”. The firm earned “Outperform” rating on Friday, January 29 by FBR Capital. Robert W. Baird initiated Proofpoint, Inc. (NASDAQ:PFPT) on Tuesday, November 15 with “Outperform” rating. The stock of Proofpoint, Inc. (NASDAQ:PFPT) has “Sell” rating given on Tuesday, August 18 by Zacks. The rating was reinitiated by Stifel Nicolaus on Tuesday, September 29 with “Buy”. The stock of Proofpoint, Inc. (NASDAQ:PFPT) earned “Buy” rating by RBC Capital Markets on Sunday, November 5. FBR Capital maintained Proofpoint, Inc. (NASDAQ:PFPT) on Friday, July 24 with “Outperform” rating. Morgan Stanley maintained Proofpoint, Inc. (NASDAQ:PFPT) rating on Thursday, July 20. Morgan Stanley has “Overweight” rating and $102 target.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 earnings per share, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62B for 21.42 P/E if the $1.72 EPS becomes a reality. After $1.90 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Montecito Bank & Trust, which manages about $288.71 million US Long portfolio, upped its stake in Ishares Core Msci Eafe Etf (IEFA) by 94,383 shares to 190,175 shares, valued at $12.20 million in 2017Q3, according to the filing. It also increased its holding in Ishares Jpmorgan Usd Emerging (EMB) by 21,465 shares in the quarter, for a total of 74,579 shares, and has risen its stake in Ishares Msci Emerging Mkt Etf (EEM).

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 86 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, January 2 the stock rating was downgraded by JP Morgan to “Neutral”. The firm has “Neutral” rating given on Monday, March 14 by Goldman Sachs. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) rating on Thursday, August 24. Cowen & Co has “Buy” rating and $147.0 target. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, October 18 report. The company was downgraded on Wednesday, September 20 by Goldman Sachs. On Tuesday, December 1 the stock rating was upgraded by Barclays Capital to “Overweight”. On Tuesday, August 15 the stock rating was maintained by Jefferies with “Hold”. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by BMO Capital Markets on Thursday, October 5. BMO Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Monday, July 10. BMO Capital Markets has “Buy” rating and $13200 target. As per Friday, June 2, the company rating was maintained by BMO Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: